SI2105135T1 - Farmacevtski sestavki za zdravljenje raka - Google Patents

Farmacevtski sestavki za zdravljenje raka

Info

Publication number
SI2105135T1
SI2105135T1 SI200332400T SI200332400T SI2105135T1 SI 2105135 T1 SI2105135 T1 SI 2105135T1 SI 200332400 T SI200332400 T SI 200332400T SI 200332400 T SI200332400 T SI 200332400T SI 2105135 T1 SI2105135 T1 SI 2105135T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical compositions
treating cancer
cancer
treating
pharmaceutical
Prior art date
Application number
SI200332400T
Other languages
English (en)
Inventor
Jerome B. Zeldis
Original Assignee
Celgene Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corporation filed Critical Celgene Corporation
Priority claimed from EP09008756.0A external-priority patent/EP2105135B1/en
Publication of SI2105135T1 publication Critical patent/SI2105135T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035Isoindoles, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200332400T 2002-05-17 2003-05-16 Farmacevtski sestavki za zdravljenje raka SI2105135T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38084202P 2002-05-17 2002-05-17
US42460002P 2002-11-06 2002-11-06
EP09008756.0A EP2105135B1 (en) 2002-05-17 2003-05-16 Pharmaceutical compositions for treating cancer

Publications (1)

Publication Number Publication Date
SI2105135T1 true SI2105135T1 (sl) 2015-01-30

Family

ID=49449200

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332400T SI2105135T1 (sl) 2002-05-17 2003-05-16 Farmacevtski sestavki za zdravljenje raka

Country Status (4)

Country Link
CA (2) CA2855359A1 (sl)
DK (1) DK2105135T3 (sl)
NZ (1) NZ595125A (sl)
SI (1) SI2105135T1 (sl)

Also Published As

Publication number Publication date
NZ595125A (en) 2013-10-25
CA2855359A1 (en) 2003-11-27
DK2105135T3 (da) 2014-11-03
CA2855306A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
TWI350751B (en) Pharmaceutical compositions for treating diabetes
EP1535610A4 (en) THERAPEUTIC CANCER
GB2389530B (en) Pharmaceutical compositions
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
EP1468118A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
GB2391473B (en) Pharmaceutical compositions
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
ZA200500431B (en) Medicinal composition for treating arteriosclerosis
EP1551388A4 (en) COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME
EP1626711A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
IL168059A0 (en) Benzopyranone compounds, compositions thereof, and methods for treating orpreventing cancer
AU2003222449A1 (en) Medicine for treating cancer
HUP0600855A2 (en) Androgen pharmaceutical composition for treating depression
HUP0500199A2 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
GB0213481D0 (en) Pharmaceutical compositions
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU2003298708A8 (en) Gpc99 and gpc99a: methods and compositions for treating cancer
EP1587405A4 (en) NEW COMPOSITIONS AND METHODS OF CANCER
HUP0200253A2 (en) Pharmaceutical compositions for combination therapy
SI2105135T1 (sl) Farmacevtski sestavki za zdravljenje raka
GB0223325D0 (en) Treating cancer
EP1712619A4 (en) SUBSTANCE FOR THE PREVENTION AND TREATMENT OF CANCER
PL370907A1 (en) Pharmaceutical compositions